Abstract
Pregabalin is a newer generation gabapentinoid and is structurally similar to the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Gabapentin was initially synthesised over forty years ago as an adjuvant antiepileptic drug but has since become widely prescribed to treat neuropathic pain. Similarly, pregabalin use in epilepsy is limited and its use has been targeted for the treatment of neuropathic pain.
Cite
CITATION STYLE
APA
Chunder, R. (2022). Pregabalin. SA Pharmaceutical Journal. Medpharm Publications. https://doi.org/10.1177/1526924816654832
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free